AzTrials
AzTrials

Bariatric Surgery CandidateCIBuSNCT04990947

Direct Measurement of Food Intake Behaviour in Obese Women Before and After Bariatric Surgery or Lifestyle Intervention

An observational study of Bariatric Surgery Candidate and Lifestyle, run by Rijnstate Hospital at 1 site in Netherlands.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To assess changes in food intake and food preference (e.g., fat and sugar) after bariatric surgery and lifestyle intervention alone with a direct measurement. Read more about this study

Who is it for?
Ages 18 to 67 years, women only
Conditions the study is for
Bariatric Surgery Candidate, Lifestyle, Obesity
What is being tested?
lifestyle / RYGB
How many people
24 participants
Where
1 siteNetherlands
Study dates
7 Apr 2021to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 67 years
  • Women only
  • Adult, Older adult

Study population: RYGB or obesity with lifestyle intervention

Who may be able to join

  • Woman
  • Age between 18 and 67 years of age (standard for eligibility for bariatric surgery)
  • Patients must be able to adhere to the study visit schedule
  • Independently mobile
  • Patients must be able to give informed consent (IC) prior to any study procedures
  • Surgical (1) and non-surgical (2) groups:
  • Eligible for bariatric surgery (BMI > 35 kg/m2 and clinically indicated bariatric surgery operation in agreement with the IFSO criteria)
  • Patients with a BMI of 30-40 kg/m2, who are planning to join the COOL-lifestyle program

Who cannot join

  • Pre-operatively/lifestyle group: Factors impairing ability to consume meal such as: Significant dysphagia; Gastric outlet obstruction; Anything factor that prevents subjects from drinking or eating a meal
  • Post-operatively: Factors impairing ability to consume meal such as: Significant and persistent surgical complications or anything that prevents subjects from drinking or eating a meal.
  • Systemic or gastrointestinal condition which may affect food intake or preference (including diabetes mellitus)
  • Pregnancy or lactation, or planning to get pregnant during the study period
  • Patients who have an intolerance or allergy for one of the components of the test product (e.g. lactose)
  • Active and significant psychiatric illness including substance misuse
Show all 9Show fewer
  • Significant cognitive or communication issues
  • Medications with documented effect on food intake or food preference
  • Participating in another scientific study at the same time, if

Trial locations and contacts

1 site in 1 country.

Netherlands1 site, 1 recruiting
  • Yonta van der Burgh

    Arnhem, 6815 AD

    Yonta van der Burgh, MSc, MD, 0880058888, Yvanderburgh@Rijnstate.nl

    Recruiting

Other trials in Netherlands

About this study

To assess changes in food intake and food preference (e.g., fat and sugar) after bariatric surgery and lifestyle intervention alone with a direct measurement.

Being tested
lifestyle / RYGB
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • lifestyle / RYGBOther

    No intervention, just 2 different groups will be included

Study groups in NCT04990947
Study groupRoleWhat they receive
Bariatric surgery (Roux-en-Y Gastric Bypass)Patients who are eligible for RYGB
Receives: Other: lifestyle / RYGB
Lifestyle groupPatients with a BMI > 30 who will start a lifestyle program
Receives: Other: lifestyle / RYGB

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in caloric intake

    kcal consumed

    Measured: Before RYGB / lifestyle compared to 4 weeks, 3 months, 6 months and 12 months after RYGB / lifestyle

Secondary outcomes (3)
  1. Weight / BMI

    weight and height measurements

    Measured: baseline, 4weeks, 3 months, 6 months, 12 months

  2. Drinking microstructure over time

    Measured with the drinkometer

    Measured: baseline, 4weeks, 3 months, 6 months, 12 months

  3. Change in self-reported hunger, thirst, fullness, preference

    VAS scale 0-100

    Measured: baseline, 4weeks, 3 months, 6 months, 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2021
  2. Study start7 Apr 2021
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04990947
Sponsor's protocol ID
2020-1594
Acronym
CIBuS
Status last verified
Feb 2021
First submitted
23 Jul 2021
Last updated
5 Aug 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Bariatric Surgery Candidate and Lifestyle, run by Rijnstate Hospital at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in caloric intake (time frame: Before RYGB / lifestyle compared to 4 weeks, 3 months, 6 months and 12 months after RYGB / lifestyle). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in